Page 337 - Read Online

Page 8 of 8 Lancaster et al. Vessel Plus 2019;3:34 I http://dx.doi.org/10.20517/2574-1209.2019.16

Biochem Biophys Res Commun 2012;425:321-7.
47. Sasagawa T, Shimizu T, Sekiya S, Haraguchi Y, Yamato M, et al. Design of prevascularized three-dimensional cell-dense tissues
using a cell sheet stacking manipulation technology. Biomaterials 2010;31:1646-54.
48. Jung JH, Fu X, Yang PC. Exosomes generated from iPSC-derivatives: new direction for stem cell therapy in human heart diseases.
Circ Res 2017;120:407-17.
49. Ogle BM, Bursac N, Domian I, Huang NF, Menasché P, et al. Distilling complexity to advance cardiac tissue engineering. Sci Transl
Med 2016;8:342ps13.
50. Bargher J, Ong L, Colzani M, Davaapil H, Hofsteen P. Epicardial cells derived from human embryonic stem cells augment
cardiomyocyte-driven heart regeneration. Nat Biotechnol 2019;37:895-906.
51. Liu YW, Chen B, Yang X, Fugate JA, Kalucki FA, et al. Human embryonic stem cell-derived cardiomyocytes restore function in
infarcted hearts of non-human primates. Nat Biotechnol 2018;36:597-605.
52. Romagnuolo R, Masoudpour H, Porta-Sanchez A, Qiang B, Barry J, et al. Human Embryonic Stem Cell-Derived Cardiomyocytes
Regenerate the Infarcted Pig Heart but Induce Ventricular Tachyarrhythmias. Stem Cell Rep 2019;12:967-81.
53. Taylor DA. The Future of Tissue Engineering in Heart Transplantation. Tex Heart Inst J 2019;46:73-4.
54. Noor N, Shapira A, Edri R, Gal I, Wertheim L, et al. Tissue Engineering: 3D Printing of Personalized Thick and Perfusable Cardiac
Patches and Hearts. Adv Sci 2019;6:1970066.
55. Huang NF, Serpooshan V, Morris VB, Sayed N, Pardon G, et al. Big bottlenecks in cardiovascular tissue engineering. Commun Biol
2018;1:199.
56. Regenerative Medicine Advanced Therapy Designation. Available from:https://www.fda.gov/vaccines-blood-biologics/cellular-gene-
therapy-products/regenerative-medicine-advanced-therapy-designation. [Last accessed on 2 Sep 2019].